Can We Get More HIV-Positive Tuberculosis Patients on Antiretroviral Treatment in a Rural District of Malawi?
Salaniponi, F M L
Harries, A D
AffiliationMedical Department (HIV-TB Operational Research), Brussels Operational Centre, Médecins sans Frontières, Brussels, Belgium. firstname.lastname@example.org
MetadataShow full item record
AbstractThe World Health Organization (WHO) has set a target of treating 3 million people with antiretroviral treatment (ART) by 2005. In sub-Saharan Africa, HIV-positive tuberculosis (TB) patients could significantly contribute to this target. ART (stavudine/lamivudine/nevirapine) was initiated in Thyolo district, Malawi, in April 2003, and all HIV-positive TB patients were considered eligible and offered ART. Despite this, only 44 (13%) of 352 TB patients were eventually started on ART by the end of November 2003. Most TB patients leave hospital after 2 weeks to complete the initial phase of anti-tuberculosis treatment (rifampicin-based) in the community, and ART is offered to HIV-positive TB patients after they have started the continuation phase of treatment (isoniazid/ ethambutol). ART is only offered at hospital, while the majority of TB patients take their continuation phase of anti-tuberculosis treatment from health centres. HIV-positive TB patients therefore find it difficult to access ART. In this paper, we discuss a series of options to increase the uptake of ART among HIV-positive TB patients. The main options are: 1) to hospitalise HIV-positive TB patients with a view to starting ART in the continuation phase in hospital; 2) to decentralise ART delivery so ART can be delivered at health centres; 3) to replace nevirapine with efavirenz so ART can be started earlier in the initial phase of anti-tuberculosis treatment. Decentralisation of ART from hospitals to health centres would greatly improve ART access.
- Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
- Authors: van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE
- Issue date: 2007
- Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
- Authors: Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Vibhagool A
- Issue date: 2006 Mar
- Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi.
- Authors: Kumwenda M, Tom S, Chan AK, Mwinjiwa E, Sodhi S, Joshua M, van Lettow M
- Issue date: 2011 Dec
- Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
- Authors: Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, Firmenich P
- Issue date: 2006 Dec 27
- Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.
- Authors: Kwange SO, Budambula NL
- Issue date: 2010 Jan-Mar